Kazia Therapeutics Ltd (NAS:KZIA)
$ 5.86 -0.54 (-8.44%) Market Cap: 19.51 Mil Enterprise Value: 17.37 Mil PE Ratio: 0 PB Ratio: 4.37 GF Score: 41/100

Kazia Therapeutics Ltd Annual Shareholders Meeting Transcript

Nov 29, 2023 / 11:00PM GMT
Release Date Price: $5.99 (-6.34%)
John Friend Kazia Therapeutics Limited;Interim Chairman;Executive Director

&

Good morning, ladies, and gentlemen. My name is John Friend, and as the Interim Chairman of the Board of Kazia Therapeutics Limited, I would like to welcome you to today's meeting as the time is now 10 AM in Sydney. and a quorum is present.

I formally declare open the 2023 Annual General Meeting of Kazia Therapeutics Limited as set out in the Notice of Meeting. The 2023 Annual General Meeting is being held as a fully virtual meeting. We are joined online by my fellow Directors, Bryce Carmine, Steven Coffey, Ebru Davidson.

I'd also like to welcome Kelly Horsman and Gareth Few, our auditors from BDO. They will be available later in the meeting to answer any questions you may have about the conduct of the audit from management. I would also like to welcome Gabrielle Heaton, Vice President Finance; and Karen Krumeich, our Chief Financial Officer.

I would also like to welcome all attendees to the meeting, and I confirm that only shareholders and proxy holders are able to ask

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot